Kepos Capital LP Renovacor, Inc. Transaction History

Kepos Capital LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$1.56 - $4.29 $156,000 - $429,000	-100,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.73 - $10.65 $773,000 - $1.07 Million	100,000 New	100,000 $905,000

Ticker RCOR
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,267,700
Description
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). T...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.